A survey on infection management practices in Italian ICUs

Table 3 Antimicrobials most commonly used for empirical treatment of specific infections.

Infection/Drugs	Frequency number (%)^a	Infection/Drugs	Frequency number (%)^a
Early VAP (<5 days)		Suspected catheter-related bacteremia
Piperacillin/tazobactam Levofloxacin Ceftriaxone	37/146 (25) 25/146 (17) 19/146 (13)	Vancomycin Piperacillin/tazobactam Meropenem	70/171 (41) 21/171 (12) 15/171 (9)
Late VAP (≥5 days)		Suspected candidemia and/or invasive
Piperacillin/tazobactam Meropenem Ceftazidime	50/142 (35) 23/142 (16) 17/142 (12)	candidiasis Fluconazole Caspofungin Voriconazole	97/151 (64) 32/151 (21) 9/151 (6%)
Community-acquired pneumonia		Community-acquired peritonitis
Ceftriaxone Levofloxacin Amoxicillin/clavulanic acid	42/156 (27) 31/156 (20) 23/156 (15)	Piperacillin/tazobactam Ampicillin/sulbactam Cefotaxime	37/161 (23) 26/161 (16) 16/161 (10)
Hospital-acquired pneumonia		Postoperative peritonitis
Piperacillin/tazobactam Levofloxacin Ceftriaxone	51/171 (30) 26/171 (15) 22/171 (13)	Piperacillin/tazobactam Meropenem Ertapenem	63/165 (38) 46/165 (28) 8/165 (5)
Health-care-acquired pneumonia		Purulent meningitis
Piperacillin/tazobactam Meropenem Ceftazidime	39/143 (27) 24/143 (17) 13/143 (9)	Ceftriaxone Linezolid Cefotaxime	111/156 (71) 6/156 (4) 6/156 (4)

^aDenominators represent the number of ICUs that answered the specific question. VAP, ventilator-associated pneumonia.

ISSN: 1364-8535